Chanda Macias’ mission is to make cannabis accessible worldwide
Chanda Macias is on a mission to bring medical cannabis to the world one country at a time. With over 25 years of experience in healthcare, education and business, the CEO of National Holistic Healing Center, a licensed medical cannabis dispensary in Washington, D.C.,...
Is 280E tax relief immediate? Your top marijuana rescheduling questions answered
President Donald Trump’s Dec. 18 executive order directing the Justice Department to officially classify cannabis as a less-dangerous drug with medicinal value under federal law is historic and transformative. But marijuana rescheduling is also generating confusion,...
Three trends affecting the U.S. cannabis industry in 2026
As the U.S. cannabis industry enters 2026, shifting market dynamics are reshaping how businesses operate and compete. From licensing activity to pricing behavior, patterns that emerged in 2025 offer a clearer picture of where the regulated market is stabilizing...
Can the cannabis industry send one of its own to Congress?
Wanda James is singing a familiar tune, one fans of reggae superstar Peter Tosh know well: “Legalize it.” But will that be enough for the $32 billion U.S. cannabis industry to be like other business sectors and send one of its own to Washington? ADVERTISEMENT James, a...
Great leaps in cannabis research expected after marijuana rescheduling
Kim Rivers runs a company that deals primarily in medical cannabis. Following President Donald Trump’s Dec. 18 move to relax federal restrictions on the drug, Rivers’ Florida-headquartered Trulieve Cannabis Corp. wants to bring a marijuana-based medicine to...
What cannabis investors should watch for in 2026 after marijuana rescheduling
(This is a contributed guest column. To be considered as an MJBizDaily guest columnist, please submit your request here.) Cannabis investors are understandably optimistic heading into 2026 after President Donald Trump’s historic Dec. 18 executive order. Marijuana...
Familiar foe claims credit for campaigns to end adult-use marijuana sales in Maine, Massachusetts
Cannabis reform’s sworn enemy is claiming credit for the quests to end adult-use marijuana sales in Maine and Massachusetts, where in the latter state signature-gatherers are allegedly resorting to deceptive tactics. Smart Approaches to Marijuana, a Washington,...
Credit cards, advertising and more: Cannabis rescheduling means business opportunities
In the wake of President Donald Trump moving reschedule cannabis last week, operators in the $32 billion legal cannabis industry are rolling out their growth strategies. Marijuana multistate operators such as Massachusetts-based MariMed, New York-headquartered Ascend...
Marijuana MSO Curaleaf’s Virginia expansion unravels amid more lucrative offer
Less than three weeks after announcing an ambitious $110 million expansion into Virginia, where adult-use marijuana sales are expected to begin sometime next year, Curaleaf Holdings’ purchase of competitor The Cannabist Company Holdings’ assets in the state is off....
When is marijuana officially rescheduled? Schedule 3 timeline is unclear – and has risks
One day after President Donald Trump’s long-anticipated executive order directing federal authorities to reclassify cannabis as a less dangerous drug, the $32 billion legal U.S. cannabis industry is posing a central question: When? Trump’s order instructs Attorney...
Why marijuana rescheduling is a real shift, but not the finish line
(This is a contributed guest column. To be considered as an MJBizDaily guest columnist, please submit your request here.) President Donald Trump’s historic executive order Thursday expediting the reclassification of cannabis from Schedule 1 to Schedule 3 is the most...Featured
1
Latest Sponsored
